Boeing and GM move to sell HRL Laboratories to IBM under definitive agreement

Boeing and General Motors have signed a definitive agreement to sell HRL Laboratories, a 50-50 joint venture owned by the two companies, to IBM, the companies said in a joint announcement. The deal would transfer HRL’s research and technology capabilities to IBM, with an agreement that begins the regulatory review process and no transaction price disclosed. The move comes as Boeing said it wants to focus resources on its core businesses while continuing selected work with IBM in quantum and advanced technology development.

HRL Laboratories, founded in 1948, has been positioned as a technology developer spanning multiple industries, including automotive, aerospace and defense. In the companies’ statement, HRL was described as delivering “transformative technologies” and as a leader in physical science and engineering research. Under the proposed sale, Boeing and GM indicated they will continue collaborating with IBM even as they step back from owning the lab itself.

Boeing and GM said the agreement is definitive and therefore marks a formal step beyond preliminary discussions, but they did not provide a timeline for closing. The transaction, they said, “starts the regulatory review process.” That phrase indicates that approval from government or industry regulators is expected before the companies can complete the transfer.

The joint statement emphasized that HRL’s history and capabilities would remain part of IBM’s roadmap. The statement read, in part, that since HRL’s founding in 1948 it has been a leader in pioneering work in physical science and engineering, and that the partners look forward to IBM building on that legacy. It also framed the sale as an effort to concentrate each parent’s resources on its respective core programs and customer needs.

Boeing said that while the proposed sale would occur, the two automaker and aerospace partners will continue working with IBM on quantum applications and advanced technology development. Quantum applications refer to software and systems designed to run on quantum computing or to use quantum-inspired approaches, a field companies often pursue to explore next-generation computing and materials science. The statement suggested these collaborations are likely to continue even after the ownership change at HRL.

Boeing described IBM as a future builder of HRL’s “legacy,” while also stressing a shift in internal focus. The companies did not disclose financial details, which leaves open questions about how the sale affects Boeing and GM’s investment plans, cash flow, or the value attributed to HRL’s research portfolio. Without transaction terms, analysts will likely look for follow-on disclosures in regulatory filings or later company updates.

From Boeing’s standpoint, HRL had been part of a broader ecosystem of advanced engineering work that can intersect with aerospace systems, defense technology, and manufacturing innovation. Boeing also stated it is committed to operating with safety, quality and integrity and that its workforce and supplier base support innovation and other long-term priorities. In this narrative, the HRL sale is framed less as a retreat from research and more as a refocusing of where the groups want to place resources.

The defense sector context matters because research laboratories and applied technology development can feed into defense-adjacent capabilities, even if specific programs are not named in the announcement. HRL’s stated coverage of automotive, aerospace and defense suggests the lab’s work touches multiple lines of business. By moving HRL under IBM, Boeing and GM could be restructuring how they access technology development that spans beyond their individual corporate boundaries.

Still, important details remain undisclosed. The companies did not provide financial terms, the expected timing to complete the regulatory review, or how the sale would affect staff, ongoing projects, or intellectual property arrangements at HRL. They also did not specify what portion of quantum and advanced technology work would be conducted through IBM after the transaction, beyond the general commitment to continue collaboration.

Investors and industry observers will likely watch for regulatory filings connected to the proposed transaction and for any subsequent company disclosures about the scope of post-sale collaboration. Additional clarity on deal value, governance of the continuing IBM partnerships, and how the shift affects HRL’s current research programs could shape how the market interprets the strategic logic of the move.